BioWraptor stabilizes fragile biomolecules at room temperature using a simple, peptide-based encapsulation method. By eliminating the need for cold storage, it cuts costs, reduces emissions, and expands access to diagnostics, vaccines, and biologics —unlocking new possibilities in healthcare, agriculture, and sustainable biotech.
FELLOW
Maeva Coste
Maeva Coste is the co‑founder and CEO of BioWraptor, a company that protects fragile biomolecules from heat, light, and oxidative degradation using peptide‑based microspheres. Originally from southern France, she earned a Ph.D. in chemistry and biomolecular engineering from the University of Montpellier, then pursued postdoctoral research at CUNY’s Advanced Science Research Center, where she co‑developed the technology behind BioWraptor. Before launching BioWraptor, Coste advised life‑science startups and participated in industry-academic innovation partnerships.
TECHNOLOGY
Critical Need
Many biotech products—such as diagnostic tests, vaccines, bioassays, biopesticides, and therapeutics—rely on fragile biomolecules that rapidly degrade and lose their activity without refrigeration. This dependence on cold storage drives up costs and losses, reduces access, contributes significantly to greenhouse gas emissions, and limits the development of new products. There is an urgent need for new methods of stabilizing biomolecules at room temperature that go far beyond the scope of current solutions.
Technology Vision
BioWraptor’s technology is composed of designed peptides that form a protective “wrap” around fragile biomolecules—vitamins, proteins, enzymes, and more—coating them and upon drying locking them into room-temperature-stable microspheres. This dynamic coating forms spontaneously, as the peptide envelopes biomolecules; a simple mix-and-dry step then triggers phase separation, encapsulating the cargo in robust microspheres. These particles resist heat, light, and oxidation, yet dissolve instantly with a drop of water, releasing fully active biomolecules. Cheap, versatile, and energy-free, BioWraptor’s technology preserves function in solution or powder, widening global access to life-saving diagnostics, therapeutics, and sustainable biomanufacturing while unlocking molecules once considered too unstable to use.
Potential for Impact
BioWraptor’s technology has the potential to change many industries by improving accessibility, lowering costs, and supporting sustainability goals. Without reliance on refrigeration during storage and transport, diagnostic tests can reach remote clinics at a much lower cost, vaccines can travel to off-grid communities, and research reagents can ship by regular mail. Skipping freezers and dry ice flights cuts logistics costs by up to 80 percent, slashes CO₂ emissions, and shrinks waste. The same peptide-based protective coating can also open new paths in healthcare, agriculture, and industrial biotech. By protecting biologics, BioWraptor boosts global health and climate resilience.